Metabolomics as a Tool for Discovery – PLOS | ONE article
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age.
Posters & Publications
- Some great book recommendations for families learning about autism. These books contain real-world, practical thin… https://t.co/txU9EdAjECyesterday
- Our test looks for certain metabolic imbalances that have been identified through our clinical study to be associat… https://t.co/Pg7LzXICVa6 days ago
- RT @Spectrum: Autism may look different in adults than it does in children, making diagnosing adults harder. https://t.co/279P8TuXci8 days ago